Gisela A. Paulsen, MPharm

Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.

DigitalDx Ventures is a majority woman-owned impact fund on a mission to transform global healthcare through early, accurate, and accessible diagnosis. We invest at the intersection of AI, big data, and medical innovation to address some of the world’s most pressing health challenges — including breast and other cancers, cardiovascular and kidney diseases, Alzheimer’s, and mental health. Our team brings together successful Silicon Valley digital health investors, as well as leading medical and legal experts, to identify and support groundbreaking technologies that: Enable earlier, more precise detection Minimize invasiveness in diagnosis and treatment Lower costs and expand access to care At DigitalDx, we believe that smarter diagnostics save lives. By backing bold entrepreneurs and next-generation platforms, we aim to improve health outcomes for millions — while delivering meaningful returns and measurable impact.

Portfolia is the most powerful community of women and men investing in the companies we want in the world. Our collective investments are changing health, active aging & longevity, sustainability, education, and the overall venture capital landscape while also backing diversity. Our currently open funds are Femtech III, focused on enhancing the wellness of all women, and advancing innovation in womens health; and Active Aging & Longevity II, focused on significant opportunities and challenges in aging well, as well as those focused on new strides and technologies in the field of longevity. We drive change while creating wealth. If youd like to join us, email investorrelations@portfolia.com, and our Investor Relations Team will contact you.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation